Melexis: The Next Growth Phase is Driven by Robotic Cars and Humanoids. Morgan Stanley Upgrades to Overweight!

Melexis (WKN 909765) is an exciting stock at the intersection of robotic vehicles and humanoid robots. On June 24, 2025, Morgan Stanley rated it as Overweight with a price target of €80. Analysts are pointing out a cyclical recovery in the automotive sector and increased design wins from China as the main drivers. Accordingly, Melexis is exiting its short-term sideways phase and continuing to trend towards the big picture breakout. With Melexis, you can play two stories. First, the rising chip content due to the transition to electrified robotic...